| License: Allianz- bzw. Nationallizenz PDF - Published Version (528kB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-361462
- DOI to cite this document:
- 10.5283/epub.36146
Abstract
Background: Patients with encephalitis associated with antibodies against N-methyl-D-aspartate-receptor antibody (NMDAR-ab) encephalitis frequently show psychotic symptoms, amnesia, seizures and movement disorders. While brain MRI in NMDAR-ab encephalitis is often normal, abnormalities of cerebral glucose metabolism have been demonstrated by positron emission tomography (PET) with ...
Owner only: item control page